Anionic Pulmonary Surfactant Lipid Treatment Inhibits Rhinovirus A Infection of the Human Airway Epithelium

Anionic Pulmonary Surfactant Lipid Treatment Inhibits Rhinovirus A Infection of the Human Airway Epithelium

Rhinoviruses (RVs) are major instigators of acute exacerbations of asthma, COPD, and other respiratory diseases. RVs are categorized into three species (RV-A, RV-B, and RV-C), which comprise more than 160 serotypes, making it difficult to develop an effective vaccine. Currently, no effective treatme...

Full description

Bibliographic Details
Main Authors: Mari Numata, Satria Sajuthi, Yury A. Bochkov, Jessica Loeffler, Jamie Everman, Eszter K. Vladar, Riley A. Cooney, Richard Lee Reinhardt, Andrew H. Liu, Max A. Seibold, Dennis R. Voelker
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Viruses
Subjects:
antiviral
innate immunity
primary human airway epithelial cells
replication organelle
human phosphatidylinositol 4-kinases
Online Access:https://www.mdpi.com/1999-4915/15/3/747

Similar Items

Similar Items